Issue 1/2010

Psychological well−being in advanced NSCLC patients in Serbia: impact of sociodemographic and clinical factors (1 — 7)

D. M. MARIC, D. M. JOVANOVIC, I. V. GOLUBICIC, L. J. NAGORNI-OBRADOVIC, J. M. STOJSIC, T. D. PEKMEZOVIC

DOI: 10.4149/neo_2010_01_001

Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma (8 — 14)

J. MINARIK, V. SCUDLA, J. BACOVSKY, M. ZEMANOVA, T. PIKA, M. ORDELTOVA, K. LANGOVA

DOI: 10.4149/neo_2010_01_008

CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival (15 — 19)

D. VRANA, J. NOVOTNY, I. HOLCATOVA, I. HLAVATA, P. SOUCEK

DOI: 10.4149/neo_2010_01_015

Comparative study of the immunohistochemical expression of metalloproteinases 2, 7 and 9 between clearly invasive carcinomas and “in situ” trophoblast invasion (20 — 28)

I. IOANNIDIS, B. DIMO, A. KARAMERIS, G. VILARAS, H. GAKIOPOULOU, E. PATSOURIS, A. C. LAZARIS

DOI: 10.4149/neo_2010_01_020

Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma (29 — 34)

L. POUR, H. SVACHOVA, Z. ADAM, Z. MIKULKOVA, L. BURESOVA, L. KOVAROVA, T. BUCHLER, M. PENKA, J. VORLICEK, R. HAJEK

DOI: 10.4149/neo_2010_01_029

Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters (35 — 40)

Z. LASABOVA, P. TILANDYOVA, K. KAJO, P. ZUBOR,  T. BURJANIVOVA, J. DANKO, L. PLANK

DOI: 10.4149/neo_2010_01_035

Immunoelectron microscopy in mycosis fungoides and benign dermatoses. Expression of CD3, CD4 and CD7 receptors (41 — 46)

A. A. GRZANKA, W. PLACEK, A. GRZANKA, M. SOKOLOWSKA-WOJDYLO, A. ZURYN

DOI: 10.4149/neo_2010_01_041

A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer (47 — 54)

G. PENTHEROUDAKIS, L. KOSTADIMA, L. DOVA, I. GEORGIOU, T. TZAVARAS, G. VARTHOLOMATOS, R. M. WIRTZ, G. FOUNTZILAS, V. MALAMOU-MITSI, N. PAVLIDIS

DOI: 10.4149/neo_2010_01_047

Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer (55 — 61)

R. JING, M. CUI, J. WANG, H. WANG

DOI: 10.4149/neo_2010_01_055

Expression and its clinical significance of heat shock protein gp96 in human osteosarcoma (62 — 67)

W. C. GUO, S. H. ZHAO, L. YU, J. TANG, G. X. WU, J. L. CHEN

DOI: 10.4149/neo_2010_01_062

The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors (68 — 73)

S. PAVLOVIC, V. ARTIKO, D. SOBIC-SARANOVIC, S. DAMJANOVIC, B. POPOVIC, R. JAKOVIC, Z. PETRASINOVIC, E. JAKSIC, M. TODOROVIC-TIRNANIC, D. SARANOVIC, M. MICEV, S. NOVOSEL, N. NIKOLIC, V. OBRADOVIC

DOI: 10.4149/neo_2010_01_068

Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women (74 — 78)

S. N. RAHEEM, M. ATOUM, H. AL-HOURANI, M. RASHEED, N. NIMER, T. ALMUHRIB

DOI: 10.4149/neo_2010_01_074

Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939 (79 — 85)

J. B. WANG, L. X. LIU, S. H. PAN, C. Y. WANG, Q. F. FU

DOI: 10.4149/neo_2010_01_079

Polymorphism in heme oxygenase-1 (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males (86 — 92)

J. L. HU, Z. Y. LI, W. LIU, R. G. ZHANG, G. L. LI, T. WANG, J. H. REN, G. WU

DOI: 10.4149/neo_2010_01_086